-
中文名称:小鼠凝血酶抗凝血酶复合物(TAT)酶联免疫试剂盒
-
货号:CSB-E08433m
-
规格:96T/48T
-
价格:¥3200/¥2500
-
其他:
产品详情
-
产品描述:CUSABIO小鼠凝血酶抗凝血酶复合物(TAT)酶联免疫检测试剂盒(货号:CSB-E08433m),主要用于定量检测血清、血浆及组织匀浆样本中的TAT含量。TAT是凝血酶与抗凝血酶结合形成的复合物,其水平直接反映体内凝血与抗凝血系统的动态平衡,常用于评估凝血激活状态及相关病理机制研究。试剂盒采用双抗体夹心法原理,检测范围覆盖15.6-1000 pg/mL,可精准捕捉低丰度TAT分子,适用于小鼠模型的血栓性疾病、弥散性血管内凝血(DIC)等凝血功能障碍研究,或药物干预下凝血/抗凝血系统调控机制的体外实验分析。试剂盒包含预包被特异性抗体的酶标板、标准品、检测抗体及显色系统,操作流程标准化,3.5小时内即可完成检测,且样本兼容性强,支持多种生物基质检测,为心血管疾病、炎症反应或肿瘤相关凝血异常的动物模型研究提供可靠工具。
-
别名:N/A
-
缩写:TAT
-
种属:Mus musculus (Mouse)
-
样本类型:serum, plasma, tissue homogenates
-
检测范围:15.6 pg/mL-1000 pg/mL
-
灵敏度:3.9 pg/mL
-
反应时间:1-5h
-
样本体积:50-100ul
-
检测波长:450 nm
-
研究领域:Cardiovascular
-
测定原理:quantitative
-
测定方法:Sandwich
-
精密度:
Intra-assay Precision (Precision within an assay): CV%<8% Three samples of known concentration were tested twenty times on one plate to assess. Inter-assay Precision (Precision between assays): CV%<10% Three samples of known concentration were tested in twenty assays to assess. -
线性度:
To assess the linearity of the assay, samples were spiked with high concentrations of mouse TAT in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. Sample Serum(n=4) 1:10 Average % 87 Range % 82-93 1:20 Average % 95 Range % 90-101 1:40 Average % 105 Range % 96-112 1:80 Average % 93 Range % 87-98 -
回收率:
The recovery of mouse TAT spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. Sample Type Average % Recovery Range Serum (n=5) 95 93-100 EDTA plasma (n=4) 90 85-96 -
标准曲线:
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. pg/ml OD1 OD2 Average Corrected 1000 2.658 2.456 2.557 2.374 500 2.214 2.113 2.164 1.981 250 1.503 1.522 1.513 1.330 125 0.855 0.904 0.880 0.697 62.5 0.542 0.563 0.553 0.370 31.2 0.413 0.435 0.424 0.241 15.6 0.291 0.302 0.297 0.114 0 0.188 0.178 0.183 -
数据处理:
-
货期:3-5 working days
引用文献
- Pretreatment with Eupatilin Attenuates Inflammation and Coagulation in Sepsis by Suppressing JAK2/STAT3 Signaling Pathway Y Lu,Journal of inflammation research,2023
- Fibroblast growth factor 2 (FGF2) ameliorates the coagulation abnormalities in sepsis Y Sun,Toxicology and applied pharmacology,2023
- Piperlongumin Improves Survival in the Mouse Model of Sepsis: Effect on Coagulation Factors and Lung Inflammation Z Fang,Inflammation,2022
- Beta-naphthoflavone Regulates Inflammation and Coagulation of Sepsis by Raising Nrf2/Ho-1 and Involving AKT/NF-κB Signaling Pathways W Chen,researchsquare,2022
- HSF1 Alleviates Microthrombosis and Multiple Organ Dysfunction in Mice with Sepsis by Upregulating the Transcription of Tissue-Type Plasminogen Activator T Li,Thromb Haemost,2021
- Thrombin-Activatable Fibrinolysis Inhibitor Protects Against Acute Lung Injury by Inhibiting the Complement System Naito M et al,Am J Respir Cell Mol Biol,2013
相关产品
Most popular with customers
-
Human Transforming Growth factor β1,TGF-β1 ELISA kit
Detect Range: 23.5 pg/ml-1500 pg/ml
Sensitivity: 5.8 pg/ml
-
-
-
Mouse Tumor necrosis factor α,TNF-α ELISA Kit
Detect Range: 7.8 pg/ml-500 pg/ml
Sensitivity: 1.95 pg/ml
-
-
-
-